25
Participants
Start Date
August 12, 2021
Primary Completion Date
April 29, 2022
Study Completion Date
April 29, 2022
submucosal 8 mg (2 mL) dexamethasone application
The mucoperiosteal flap was applied. After operation, submucosal dexamethasone 8 mg (2 mL) was applied to the operation area as a test group.
submucosal 2 mL 0.9% isotonic sodium chloride application
The mucoperiosteal flap was applied. After operation, 2 mL 0.9% isotonic sodium chloride was applied to the operation area as a control group
Van Yuzuncu Yil University, Van
Yuzuncu Yıl University
OTHER